Angiogeneseremmers voor de systemische behandeling van gemetastaseerd niercelcarcinoom: sunitinib, sorafenib, bevacizumab en temsirolimus

Translated title of the contribution: Angiogenesis inhibitors for the systemic treatment of metastatic renal cell carcinoma: sunitinib, sorafenib, bevacizumab and temsirolimus
  • PH de Mulder
  • , John B. Haanen
  • , Stefan Sleijfer
  • , Wim H. Kruit
  • , Jourik A. Gietema
  • , DJ Richel
  • , G. Groenewegen
  • , EE Voest
  • , AJM van den Eertwegh
  • , S Osanto
  • , RLH Jansen
  • , PF Mulders

    Research output: Contribution to journalArticleAcademicpeer-review

    2 Citations (Scopus)
    36 Downloads (Pure)
    Translated title of the contributionAngiogenesis inhibitors for the systemic treatment of metastatic renal cell carcinoma: sunitinib, sorafenib, bevacizumab and temsirolimus
    Original languageDutch
    Pages (from-to)371-375
    Number of pages5
    JournalNederlands Tijdschrift voor Geneeskunde
    Volume152
    Publication statusPublished - 16-Feb-2008

    Cite this